Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.

Yamada H, Kobayashi R, Shimizu S, Yamada Y, Ishida M, Shimoda H, Kato-Hayashi H, Fujii H, Iihara H, Tanaka H, Suzuki A.

Int J Clin Pract. 2020 Apr;74(4):e13464. doi: 10.1111/ijcp.13464. Epub 2019 Dec 19.

PMID:
31830345
2.

Role of dynamic nuclear deformation on genomic architecture reorganization.

Seirin-Lee S, Osakada F, Takeda J, Tashiro S, Kobayashi R, Yamamoto T, Ochiai H.

PLoS Comput Biol. 2019 Sep 11;15(9):e1007289. doi: 10.1371/journal.pcbi.1007289. eCollection 2019 Sep.

3.

Electronic States and Transport Phenomena of Pt Nanoparticle Catalysts Supported on Nb-Doped SnO2 for Polymer Electrolyte Fuel Cells.

Kakinuma K, Suda K, Kobayashi R, Tano T, Arata C, Amemiya I, Watanabe S, Matsumoto M, Imai H, Iiyama A, Uchida M.

ACS Appl Mater Interfaces. 2019 Sep 25;11(38):34957-34963. doi: 10.1021/acsami.9b11119. Epub 2019 Sep 16.

PMID:
31490657
4.

Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.

Yamada Y, Ohno Y, Kato Y, Kobayashi R, Hayashi H, Miyahara S, Nakane K, Mizutani K, Yokoi S, Fujii H, Iihara H, Ishihara T, Deguchi T, Sugiyama T, Suzuki A.

Cancer Chemother Pharmacol. 2019 Nov;84(5):987-992. doi: 10.1007/s00280-019-03935-x. Epub 2019 Sep 3.

PMID:
31482225
5.

Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical Examination.

Oda K, Okada H, Suzuki A, Tomita H, Kobayashi R, Sumi K, Suzuki K, Takada C, Ishihara T, Suzuki K, Kano S, Kondo K, Iwashita Y, Yano H, Zaikokuji R, Sampei S, Fukuta T, Kitagawa Y, Okamoto H, Watanabe T, Kawaguchi T, Kojima T, Deguchi F, Miyazaki N, Yamada N, Doi T, Yoshida T, Ushikoshi H, Yoshida S, Takemura G, Ogura S.

J Clin Med. 2019 Aug 27;8(9). pii: E1320. doi: 10.3390/jcm8091320.

6.

Clonality investigation of clinical Escherichia coli isolates by polymerase chain reaction-based open-reading frame typing method.

Saeki M, Sato T, Furuya D, Yakuwa Y, Sato Y, Kobayashi R, Ono M, Nirasawa S, Tanaka M, Nakafuri H, Nakae M, Shinagawa M, Asanuma K, Yanagihara N, Yokota SI, Takahashi S.

J Infect Chemother. 2020 Jan;26(1):38-42. doi: 10.1016/j.jiac.2019.06.014. Epub 2019 Jul 27.

PMID:
31362903
7.

Evaluation of the Diabetes Regional Coordination Path using the Diabetes Coordination Notebook in community-based diabetes care.

Horikawa Y, Suzuki A, Hashimoto KI, Enya M, Nishida S, Kobayashi R, Ohashi T, Yamazaki F, Totani R, Kobayashi H, Yamamoto M, Itoh Y, Takeda J.

Diabetol Int. 2018 Oct 20;10(3):188-197. doi: 10.1007/s13340-018-0379-6. eCollection 2019 Jul.

8.

An Isolable Silicon Analogue of a Ketone that Contains an Unperturbed Si=O Double Bond.

Kobayashi R, Ishida S, Iwamoto T.

Angew Chem Int Ed Engl. 2019 Jul 8;58(28):9425-9428. doi: 10.1002/anie.201905198. Epub 2019 Jun 18.

PMID:
31095845
9.

Periodontal Disease May be Associated With the Occurrence of Diabetic Retinopathy: A Subgroup Analysis of The Survey of the Diabetes Coordination Notebook in Gifu.

Horikawa Y, Suzuki A, Enya M, Hashimoto KI, Nishida S, Kobayashi R, Ohashi T, Yamazaki F, Totani R, Kobayashi H, Yamamoto M, Itoh Y, Takeda J.

Exp Clin Endocrinol Diabetes. 2019 Apr 11. doi: 10.1055/a-0879-1890. [Epub ahead of print]

PMID:
30974473
10.

A case of pulmonary histoplasmosis diagnosed after lung lobectomy.

Tanaka S, Kobayashi R, Nagita H, Okamoto K, Iida Y, Hongo K, Ishihara Y, Kita Y, Takabayashi N, Kuriki K, Hiramatsu T.

Surg Case Rep. 2018 Dec 20;4(1):145. doi: 10.1186/s40792-018-0554-9.

11.

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.

Iihara H, Fujii H, Yoshimi C, Kobayashi R, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A.

Cancer Chemother Pharmacol. 2019 Mar;83(3):393-398. doi: 10.1007/s00280-018-3736-z. Epub 2018 Dec 18.

12.

Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy.

Yamada Y, Fujii H, Watanabe D, Kato-Hayashi H, Ohata K, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Shimizu M, Suzuki A.

Cancers (Basel). 2018 Nov 16;10(11). pii: E454. doi: 10.3390/cancers10110454.

13.

Random migration of induced pluripotent stem cell-derived human gastrulation-stage mesendoderm.

Yamamoto Y, Miyazaki S, Maruyama K, Kobayashi R, Le MNT, Kano A, Kondow A, Fujii S, Ohnuma K.

PLoS One. 2018 Sep 10;13(9):e0201960. doi: 10.1371/journal.pone.0201960. eCollection 2018.

14.

Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates.

Kobayashi R, Abe M, Oguri K, Torikai M, Nishimura T, Mori H, Koshizuka T, Inoue N.

Vaccine. 2018 Sep 25;36(40):5983-5989. doi: 10.1016/j.vaccine.2018.08.054. Epub 2018 Aug 30.

PMID:
30174240
15.

Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.

Funato M, Ozeki M, Suzuki A, Ishihara M, Kobayashi R, Nozawa A, Yasue S, Endo-Ohnishi S, Fukao T, Itoh Y.

Anticancer Res. 2018 Aug;38(8):4691-4697. doi: 10.21873/anticanres.12775.

PMID:
30061237
16.

Vaccine Development for Cytomegalovirus.

Inoue N, Abe M, Kobayashi R, Yamada S.

Adv Exp Med Biol. 2018;1045:271-296. doi: 10.1007/978-981-10-7230-7_13. Review.

PMID:
29896672
17.

Fluctuating Carbonaceous Networks with a Persistent Molecular Shape: A Saddle-Shaped Geodesic Framework of 1,3,5-Trisubstituted Benzene (Phenine).

Ikemoto K, Lin J, Kobayashi R, Sato S, Isobe H.

Angew Chem Int Ed Engl. 2018 Jul 9;57(28):8555-8559. doi: 10.1002/anie.201803984. Epub 2018 Jun 6.

PMID:
29757487
18.

Relationship between number of drugs and duration of hospital stay in older patients with neuromuscular diseases.

Nishida S, Hayashi Y, Suzuki A, Kobayashi R, Inuzuka T, Itoh Y.

Geriatr Gerontol Int. 2018 Jul;18(7):1018-1024. doi: 10.1111/ggi.13292. Epub 2018 Mar 7.

PMID:
29512265
19.

Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer.

Nawa-Nishigaki M, Kobayashi R, Suzuki A, Hirose C, Matsuoka R, Mori R, Futamura M, Sugiyama T, Yoshida K, Itoh Y.

Anticancer Res. 2018 Feb;38(2):877-884.

PMID:
29374715
20.

Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.

Fujii H, Iihara H, Kajikawa N, Kobayashi R, Suzuki A, Tanaka Y, Yamaguchi K, Yoshida K, Itoh Y.

Anticancer Res. 2017 Dec;37(12):6831-6837.

PMID:
29187462

Supplemental Content

Loading ...
Support Center